Clinical Trials Logo

Refractory Epilepsy clinical trials

View clinical trials related to Refractory Epilepsy.

Filter by:

NCT ID: NCT04771065 Recruiting - Refractory Epilepsy Clinical Trials

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Intractable Epilepsy

Start date: January 1, 2021
Phase:
Study type: Observational

Deep Brain Stimulation (DBS) of the anterior nucleus of the thalamus (ANT) has been proposed in patients with severe intractable epilepsy. When used, the transventricular approach increases the risk of bleeding due the anatomy around the entry point in the thalamus. To avoid such a complication, the investigators used a transventricular microendoscopic technique.

NCT ID: NCT04770337 Recruiting - Epilepsy Clinical Trials

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

This is a multiple site, randomized, double blinded parallel-group controlled study. The purpose of this study is to evaluate efficacy, safety, and tolerability of repeated, daily sessions with the STARSTIM device, which delivers transcranial cathodal direct current stimulation (tDCS). Subjects will be treated with STARTSTIM or sham device for 10 sessions over a 2-week period. The subjects will be followed for an additional 10 weeks post treatment. Quality of Life questionnaires and adverse events will be collected and evaluated.

NCT ID: NCT04753983 Withdrawn - Refractory Epilepsy Clinical Trials

A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy

Start date: September 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to use functional imaging to study the mechanisms of the anterior nucleus of the thalamus (ANT) deep brain stimulation (DBS).

NCT ID: NCT04684797 Recruiting - Refractory Epilepsy Clinical Trials

Localization of the Reward Positivity to ACC

Start date: March 4, 2021
Phase: N/A
Study type: Interventional

The exact function of the anterior cingulate cortex (ACC) is one of the largest riddles in cognitive neuroscience and a major challenge in mental health research. ACC dysfunction contributes to a broad spectrum of neurological and psychiatric disorders, such as depression, ADHD, Parkinson's disease, OCD and many others, but nobody knows what it actually does. Recently a new theory has been developed about ACC function; the HRL-ACC (Hierarchical Reinforcement Learning Theory of ACC). This theory proposes that the ACC selects and motivates high-level tasks based on the principles of hierarchical reinforcement learning. The ACC associates values with tasks, selects the correct tasks and applies control over other neural networks (such as the dorsolateral prefrontal cortex and basal ganglia), which execute the tasks. The values of these tasks are attributed based on "reward prediction error signals", which are sent from the midbrain dopamine system to the ACC. These signals can be recorded using scalp-EEG as an "event-related brain potential" (ERP), which is called the "reward positivity". Until this day, the exact origin of the reward positivity is not yet known. Studies have delivered strong indirect evidence that the reward positivity is generated in the ACC. However, there is an important lack of direct evidence to support this hypothesis. The goal of this study is to provide direct evidence that the reward positivity is generated in the ACC by letting a group of patients with refractory epilepsy perform the virtual T-maze task (which is known to elicit reward positivity) and simultaneously recording intracranial video-EEG.

NCT ID: NCT04607317 Terminated - Epilepsy Clinical Trials

Exercise as Adjunctive Treatment for Refractory Epilepsy

Start date: April 13, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to determine whether a 12-week telehealth aerobic exercise intervention is feasible in people with epilepsy. The study team will also gather information on the effect of the intervention on sleep and stress as mediators of seizure frequency, well as effects on epilepsy and epilepsy associated comorbidities.

NCT ID: NCT04545346 Completed - Clinical trials for Randomized Controlled Trial

The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.

NCT ID: NCT04542629 Not yet recruiting - Refractory Epilepsy Clinical Trials

Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children

Start date: October 1, 2020
Phase: Phase 4
Study type: Interventional

1. Comparison of the efficacy of Rituximab and ketogenic diet in controlling refractory seizures versus the traditional lines as corticosteroid and trace elements. 2. Improving the management of children with refractory seizures

NCT ID: NCT04496310 Recruiting - Epilepsy Clinical Trials

Tele-epic (Telemedicine for Epilepsy Care)

Tele-epic
Start date: July 9, 2020
Phase: N/A
Study type: Interventional

Epilepsy is a chronic condition that requires consistent follow-up aimed at seizure control, surveillance of comorbidities, monitoring of antiepileptic drugs (AED) levels and side effects. Patients may encounter difficulties to be assessed adequately and the disease burden is increased by the need for travelling across the country for medical consultations. Driving restrictions are a further limit to access specialized Centers able to provide an integrated approach focused on patient needs. Telemedicine (TM) offers an invaluable support to patient follow-up, joining the sparse distribution of patients in the country with the prompt availability of a team of experts. The project assesses, through a randomized controlled trial, the non-inferiority of TM in monitoring seizure control compared to usual (face-to-face) care. This approach, coupled with a new self home-sampling method for the measurement of AED levels, will reduce health care costs and simplify patients management.

NCT ID: NCT04398667 Terminated - Refractory Epilepsy Clinical Trials

European Non-interventional Study on Refractory Epilepsy With Developmental Delay

Start date: March 14, 2019
Phase:
Study type: Observational

This is a multinational, multicentre, non-interventional, retrospective data collection (manual Medical Chart Review).

NCT ID: NCT04240977 Recruiting - Refractory Epilepsy Clinical Trials

Feasibility of HOBSCOTCH Telehealth Intervention in Refractory Epilepsy

HOBSCOTCH
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to see whether a phone-intervention called HOBSCOTCH will improve health, daily functioning and quality of life among patients with refractory epilepsy. HOBSCOTCH stands for "Home-Based Self-Management and Cognitive Training Changes Lives." This study will also help to find the best ways of integrating this telehealth intervention to routine clinic use.